Bleichroeder’s Global Blood Therapeutics GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-125,000
Closed -$3.66M – 120
2021
Q4
$3.66M Hold
125,000
– – 0.57% 30
2021
Q3
$3.18M Buy
125,000
+25,000
+25% +$735K 0.52% 34
2021
Q2
$3.5M Hold
100,000
– – 0.53% 36
2021
Q1
$4.08M Buy
+100,000
New +$4.6M 0.69% 30

Other funds holding GBT

Bleichroeder's GBT Position: Q1 2022 in Review

Bleichroeder sold out of Global Blood Therapeutics (GBT) in Q1 2022, closing a stake of 125,000 shares — an estimated $3.66M sold.

Bleichroeder first reported a position in GBT in Q1 2021 and held it in 4 quarters. The position peaked at $4.08M in Q1 2021. 204 funds tracked by Wall St. Rank hold GBT as of Q1 2022.

  • Bleichroeder reported no remaining Global Blood Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Bleichroeder sold 125,000 Global Blood Therapeutics shares in Q1 2022, an estimated $3.66M.
  • Bleichroeder first reported a position in Global Blood Therapeutics in Q1 2021 and held it in 4 quarters.
  • Bleichroeder's Global Blood Therapeutics position peaked at $4.08M in Q1 2021.
  • 204 funds tracked by Wall St. Rank held Global Blood Therapeutics as of Q1 2022.

Based on Bleichroeder's 13F filing for Q1 2022, filed 11 May 2022.